Besponsa Interactions
There are 435 drugs known to interact with Besponsa (inotuzumab ozogamicin), along with 3 disease interactions. Of the total drug interactions, 110 are major, 324 are moderate, and 1 is minor.
- View all 435 medications that may interact with Besponsa
- View Besponsa disease interactions (3)
Most frequently checked interactions
View interaction reports for Besponsa (inotuzumab ozogamicin) and the medicines listed below.
- Adcetris (brentuximab)
- Adriamycin RDF (doxorubicin)
- bleomycin
- Blincyto (blinatumomab)
- CellCept (mycophenolate mofetil)
- Corlanor (ivabradine)
- Cosentyx (secukinumab)
- Elaprase (idursulfase)
- Empliciti (elotuzumab)
- Enbrel (etanercept)
- etoposide
- Exjade (deferasirox)
- Imbruvica (ibrutinib)
- Kalydeco (ivacaftor)
- Kineret (anakinra)
- Kynamro (mipomersen)
- Matulane (procarbazine)
- Norvir (ritonavir)
- Ocrevus (ocrelizumab)
- Oncovin (vincristine)
- Orfadin (nitisinone)
- prednisone
- Procysbi (cysteamine)
- Promacta (eltrombopag)
- Ravicti (glycerol phenylbutyrate)
- Repatha (evolocumab)
- Rescriptor (delavirdine)
- Simulect (basiliximab)
- Stivarga (regorafenib)
- Tecentriq (atezolizumab)
Besponsa disease interactions
There are 3 disease interactions with Besponsa (inotuzumab ozogamicin) which include:
Report options
More about Besponsa (inotuzumab ozogamicin)
- Besponsa consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Gleevec
Gleevec is targeted cancer therapy for specific types of leukemia (blood cancer), bone marrow ...
Sprycel
Sprycel is used to treat chronic myeloid leukemia and acute lymphoblastic leukemia. Learn about ...
Tavneos
Tavneos (avacopan) is a C5a receptor antagonist used for severe active ANCA-associated vasculitis ...
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Otrexup
Otrexup is used for polyarticular juvenile idiopathic arthritis, psoriasis, rheumatoid arthritis
Blinatumomab
Blinatumomab (Blincyto) is an injectable immunotherapy treatment that may be used to treat B-cell ...
Mercaptopurine
Mercaptopurine systemic is used for acute lymphoblastic leukemia, autoimmune hepatitis, crohn's ...
Dasatinib
Dasatinib is used to treat Philadelphia chromosome-positive chronic myelogenous leukemia (CML) ...
Doxorubicin
Doxorubicin systemic is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
